PBM Channel Access Leverage Express Scripts and Accredo ownership to access payer networks and patient populations in the PBM ecosystem, enabling cross-sell of specialty meds, patient support programs, and adherence services.

Accredo Channel Advantage As part of Accredo Health Group, CuraScript can tap into established distribution, logistics, and clinical support infrastructure, accelerating launches of new specialty therapies and delivering end-to-end fulfillment to manufacturers and providers.

Mid Market Scale With revenue in the 250M-500M range and 201-500 employees, CuraScript sits in a mid sized tier ideal for scalable partnerships with payers and providers seeking specialty pharmacy capacity, care programs, and data-enabled services.

Competitive Positioning Competing with CVS Specialty, Diplomat Pharmacy, and McKesson Biologics, CuraScript can differentiate through Express Scripts network, integrated PBM services, and Accredo backed operations to win strategic accounts and bundled solutions.

Domestic Growth Focus Based in the United States with room to expand within the domestic market, CuraScript/Accredo can target high growth specialty segments such as biologics and rare diseases, leveraging payer relationships, referral networks, and state level expansion to capture market share.